Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 17, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Non-small cell lung cancer.

David S Ettinger1, Wallace Akerley, Hossein Borghaei

  • 1The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Journal of the National Comprehensive Cancer Network : JNCCN
|October 12, 2012
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Margin positivity is not associated with the extent of resection for non-small cell lung cancer.

Surgery·2026
Same author

Impact of gastric ischemic preconditioning before esophagectomy on pathologic response.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2026
Same author

The effects of neoadjuvant chemoradiotherapy-related frailty by analytic morphomics in esophageal cancer.

Journal of cardiothoracic surgery·2026
Same author

Identification of isoform switching events linked with esophageal adenocarcinoma patient survival informs novel prognostic and therapeutic targets.

Cell death & disease·2026
Same author

NCCN Guidelines® Insights: Small Cell Lung Cancer, Version 2.2026.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Safety, efficacy, and patient satisfaction after esophagectomy for esophageal neuromotor disease: A single-institution experience.

JTCVS open·2025
Same journal

Measuring Equitable Care Delivery: Insights From the Health Equity Report Card (HERC) Pilot in Academic Cancer Centers.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

A Virtual Reality Psychosocial Intervention for Patients Undergoing Bone Marrow Transplantation (BMT-VR): Pilot Randomized Clinical Trial.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Nationwide Trends in Colorectal Cancer Screening by the End of the COVID-19 Pandemic: Racial/Ethnic Differences and Opportunities.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Evaluation of the Impact of Adjuvant Immunotherapy in Merkel Cell Carcinoma.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Payers' Views on Insurance Coverage for Confirmatory Diagnostics After a Noncovered Multicancer Early Detection (MCED) Test.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Surrogacy of Intermediate Clinical Endpoints for Overall Survival in Patients With Localized Muscle-Invasive Bladder Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
See all related articles
This summary is machine-generated.

Most non-small cell lung cancer (NSCLC) patients are diagnosed with advanced disease. Identifying stage IV NSCLC early prevents futile treatments and guides systemic therapy, clinical trials, or palliative care decisions.

Area of Science:

  • Oncology
  • Pulmonology
  • Medical Guidelines

Background:

  • Non-small cell lung cancer (NSCLC) frequently presents at advanced stages.
  • Stage IV NSCLC necessitates systemic therapy, clinical trials, or palliative care.

Purpose of the Study:

  • To outline management strategies for stage IV non-small cell lung cancer.
  • To emphasize the importance of identifying metastatic disease before aggressive treatment.

Main Methods:

  • Guidelines focus on stage IV NSCLC management.
  • Recommendations are based on multidisciplinary discussion.

Main Results:

  • Early identification of metastatic disease prevents unnecessary and futile treatments.
  • Discovery of metastatic disease during surgery may lead to surgical abortion.

Related Experiment Videos

Last Updated: May 17, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Conclusions:

  • Treatment decisions for stage IV NSCLC require careful consideration of metastatic status.
  • Multidisciplinary discussion is crucial for optimal patient care in advanced NSCLC.